Background JAK inhibitors are well known for the treatment of rheumatoid arthritis (RA), but
whether they can be used to treat pulmonary fibrosis, a common extra‐articular disease of …

Objective The study explored improvements in pulmonary inflammation and fibrosis in a
bovine type II collagen-induced rheumatoid arthritis-associated interstitial lung disease …

Pulmonary fibrosis (PF) is characterized by oxidative injury and excessive collagen
synthesis in lung fibroblasts, causing impaired pulmonary function and chronic lung injury …

Background Connective tissue disease associated pulmonary fibrosis is a severe clinical
application with poor prognosis, myofibroblasts which mostly evolved from lung fibroblasts …

Background and objective Systemic sclerosis (SSc) is an immune-mediated rheumatic
disease characterized by fibrosis and vascular lesions. Interstitial lung disease is an early …

Background Signal transducer and activator of transcription 3 (STAT3) protein is activated in
lung fibroblasts and alveolar type II cells (AT-II) and is thought to contribute to fibrosis in lung …

Idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis‐associated interstitial lung
disease (RA‐ILD) are two fibrotic interstitial lung diseases that share the usual interstitial …

Objective Pirfenidone (PFD) is an oral anti-fibrotic drug used for idiopathic pulmonary
fibrosis (IPF) therapy. We determined the role of activating transcription factor 3 (ATF3) and …

Background and purpose Interstitial lung disease (ILD) represents a significant complication
of rheumatoid arthritis (RA) that lacks effective treatment options. This study aimed to …

We explored whether transforming growth factor (TGF-β)/Smads signaling pathway
influences rheumatoid arthritis (RA)-associated pulmonary fibrosis (PF) and proliferation of …